These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

494 related articles for article (PubMed ID: 33203452)

  • 1. A versatile toolkit for CRISPR-Cas13-based RNA manipulation in Drosophila.
    Huynh N; Depner N; Larson R; King-Jones K
    Genome Biol; 2020 Nov; 21(1):279. PubMed ID: 33203452
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Molecular Mechanisms of RNA Targeting by Cas13-containing Type VI CRISPR-Cas Systems.
    O'Connell MR
    J Mol Biol; 2019 Jan; 431(1):66-87. PubMed ID: 29940185
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Insights Gained from RNA Editing Targeted by the CRISPR-Cas13 Family.
    Liu L; Pei DS
    Int J Mol Sci; 2022 Sep; 23(19):. PubMed ID: 36232699
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cas13d: A New Molecular Scissor for Transcriptome Engineering.
    Gupta R; Ghosh A; Chakravarti R; Singh R; Ravichandiran V; Swarnakar S; Ghosh D
    Front Cell Dev Biol; 2022; 10():866800. PubMed ID: 35433685
    [TBL] [Abstract][Full Text] [Related]  

  • 5. RNA editing with CRISPR-Cas13.
    Cox DBT; Gootenberg JS; Abudayyeh OO; Franklin B; Kellner MJ; Joung J; Zhang F
    Science; 2017 Nov; 358(6366):1019-1027. PubMed ID: 29070703
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Applications of the versatile CRISPR-Cas13 RNA targeting system.
    Kordyś M; Sen R; Warkocki Z
    Wiley Interdiscip Rev RNA; 2022 May; 13(3):e1694. PubMed ID: 34553495
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cross-cleavage activity of Cas6b in crRNA processing of two different CRISPR-Cas systems in Methanosarcina mazei Gö1.
    Nickel L; Ulbricht A; Alkhnbashi OS; Förstner KU; Cassidy L; Weidenbach K; Backofen R; Schmitz RA
    RNA Biol; 2019 Apr; 16(4):492-503. PubMed ID: 30153081
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Bacterial Enzyme Cas13 Interferes with Neurite Outgrowth from Cultured Cortical Neurons.
    Wu QW; Kapfhammer JP
    Toxins (Basel); 2021 Apr; 13(4):. PubMed ID: 33916905
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CRISPR/Cas13 effectors have differing extents of off-target effects that limit their utility in eukaryotic cells.
    Ai Y; Liang D; Wilusz JE
    Nucleic Acids Res; 2022 Jun; 50(11):e65. PubMed ID: 35244715
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Approaches to study CRISPR RNA biogenesis and the key players involved.
    Behler J; Hess WR
    Methods; 2020 Feb; 172():12-26. PubMed ID: 31325492
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Optimization of specific RNA knockdown in mammalian cells with CRISPR-Cas13.
    Burris BJD; Molina Vargas AM; Park BJ; O'Connell MR
    Methods; 2022 Oct; 206():58-68. PubMed ID: 35987443
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CRISPR-Cas13 System as a Promising and Versatile Tool for Cancer Diagnosis, Therapy, and Research.
    Palaz F; Kalkan AK; Can Ö; Demir AN; Tozluyurt A; Özcan A; Ozsoz M
    ACS Synth Biol; 2021 Jun; 10(6):1245-1267. PubMed ID: 34037380
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ubiquitous and Tissue-specific RNA Targeting in Drosophila Melanogaster using CRISPR/CasRx.
    Sun R; Brogan D; Buchman A; Yang T; Akbari OS
    J Vis Exp; 2021 Feb; (168):. PubMed ID: 33616113
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Advances in CRISPR-Cas systems for RNA targeting, tracking and editing.
    Wang F; Wang L; Zou X; Duan S; Li Z; Deng Z; Luo J; Lee SY; Chen S
    Biotechnol Adv; 2019; 37(5):708-729. PubMed ID: 30926472
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Chemically modified guide RNAs enhance CRISPR-Cas13 knockdown in human cells.
    Méndez-Mancilla A; Wessels HH; Legut M; Kadina A; Mabuchi M; Walker J; Robb GB; Holden K; Sanjana NE
    Cell Chem Biol; 2022 Feb; 29(2):321-327.e4. PubMed ID: 34343484
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficient RNA Virus Targeting via CRISPR/CasRx in Fish.
    Wang Q; Liu Y; Han C; Yang M; Huang F; Duan X; Wang S; Yu Y; Liu J; Yang H; Lu D; Zhao H; Zhang Y; Qin Q
    J Virol; 2021 Sep; 95(19):e0046121. PubMed ID: 34287045
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Programmable Inhibition and Detection of RNA Viruses Using Cas13.
    Freije CA; Myhrvold C; Boehm CK; Lin AE; Welch NL; Carter A; Metsky HC; Luo CY; Abudayyeh OO; Gootenberg JS; Yozwiak NL; Zhang F; Sabeti PC
    Mol Cell; 2019 Dec; 76(5):826-837.e11. PubMed ID: 31607545
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Discovery, classification and application of the CPISPR-Cas13 system.
    Nie X; Wang D; Pan Y; Hua Y; Lü P; Yang Y
    Technol Health Care; 2024; 32(2):525-544. PubMed ID: 37545273
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Applications of CRISPR/Cas13-Based RNA Editing in Plants.
    Kavuri NR; Ramasamy M; Qi Y; Mandadi K
    Cells; 2022 Aug; 11(17):. PubMed ID: 36078073
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CASowary: CRISPR-Cas13 guide RNA predictor for transcript depletion.
    Krohannon A; Srivastava M; Rauch S; Srivastava R; Dickinson BC; Janga SC
    BMC Genomics; 2022 Mar; 23(1):172. PubMed ID: 35236300
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 25.